Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-20

Clinical Trial Update: Observational Study on the Clinical Profile of Patients With Uncontrolled Severe Asthma Treated With Tezepelumab in Italy

View source ↗

Summary

This observational study in Italy examines the clinical profile of patients with uncontrolled severe asthma treated with tezepelumab. It is currently active but…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tezepelumab (tezepelumab)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Status: ACTIVE_NOT_RECRUITING